Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-026737

Chief Development Officer sold 8,000 shares at $14.51 ($116,080)

  • Chief Development Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-25 Exercise or conversion : show line 1 in the form +8,000 $4.30 $34,400 61,031 D
2022-07-25 Sale : show line 2 in the form −8,000 $14.51 $116,080 53,031 D
Open-market sales · 8,000 sh · avg $14.51 · $116,080

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-25 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −8,000 209,978 D
Loading xslF345X03/doc4.xml…